47 related articles for article (PubMed ID: 2773382)
1. [Low density lipoprotein distribution by flotation characteristics in normal conditions and in dyslipoproteinemias].
Medvedeva NV; Morozkin AD; Goroshkova IN; Ruuge EK; Shcherbakova IA
Vopr Med Khim; 1989; 35(3):36-41. PubMed ID: 2773382
[TBL] [Abstract][Full Text] [Related]
2. A tertiary care hospital-based study of conventional risk factors including lipid profile in proven coronary artery disease.
Goel PK; Bharti BB; Pandey CM; Singh U; Tewari S; Kapoor A; Garg N; Sinha N
Indian Heart J; 2003; 55(3):234-40. PubMed ID: 14560932
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of apoE-enriched triglyceride-rich lipoproteins in patients with coronary artery disease.
Barbagallo CM; Rizzo M; Noto D; Frasheri A; Pernice V; Rubino A; Pieri D; Pinto V; Cefalù AB; Giordano C; Notarbartolo A; Averna MR
Metabolism; 2006 May; 55(5):662-8. PubMed ID: 16631444
[TBL] [Abstract][Full Text] [Related]
4. Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.
Hayashi T; Hirano T; Yamamoto T; Ito Y; Adachi M
Metabolism; 2006 Jul; 55(7):879-84. PubMed ID: 16784958
[TBL] [Abstract][Full Text] [Related]
5. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
McDowell A; Young IS; Wisdom GB
J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
[TBL] [Abstract][Full Text] [Related]
6. [Evaluation of the precision of the Friedewald's formula for the calculation of low density lipoprotein cholesterol concentration in serum].
Chotkowska E; Kurjata P; Kupść W
Pol Merkur Lekarski; 2001 Oct; 11(64):348-51. PubMed ID: 11770317
[TBL] [Abstract][Full Text] [Related]
7. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
[TBL] [Abstract][Full Text] [Related]
8. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein abnormalities and extracoronary atherosclerosis in patients with premature ischemic heart disease.
Rubba P; Faccenda F; Iorio D; Pauciullo P; Cortese C; Spampinato N; Mancini M
Int Angiol; 1987; 6(4):331-7. PubMed ID: 3330114
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
11. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
Geiss HC; Otto C; Parhofer KG
Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
[TBL] [Abstract][Full Text] [Related]
12. Lipid profile in patients with coronary artery disease.
Haddad FH; Omari AA; Shamailah QM; Malkawi OM; Shehab AI; Mudabber HK; Shubaki MK
Saudi Med J; 2002 Sep; 23(9):1054-8. PubMed ID: 12370711
[TBL] [Abstract][Full Text] [Related]
13. Ubiquinol-10/lipids ratios in consecutive patients with different angiographic findings.
Záková P; Kand'ár R; Skarydová L; Skalický J; Myjavec A; Vojtísek P
Clin Chim Acta; 2007 May; 380(1-2):133-8. PubMed ID: 17336955
[TBL] [Abstract][Full Text] [Related]
14. [Specifics of lipid exchange in patients with atherosclerotic lesions of the coronary and cerebral arteries].
Korneva VA
Klin Med (Mosk); 2005; 83(2):44-7. PubMed ID: 15803832
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of high plasma triglyceride combined with low HDL-C levels and its association with smoking, hypertension, obesity, diabetes, sedentariness and LDL-C levels in the Canadian population. Canadian Heart Health Surveys Research Group.
Connelly PW; Petrasovits A; Stachenko S; MacLean DR; Little JA; Chockalingam A
Can J Cardiol; 1999 Apr; 15(4):428-33. PubMed ID: 10322252
[TBL] [Abstract][Full Text] [Related]
16. [High and low density lipoprotein abnormalities in coronary patients with LDL-C at target and uncontrolled HDL-C and triglycerides].
Posadas-Romero C; Posadas-Sánchez R; Juárez-Rojas JG; Medina-Urrutia A; Jorge-Galarza E; Cardoso-Saldaña G; Caracas-Portilla N; Mendoza-Peŕez E
Arch Cardiol Mex; 2008; 78(1):30-9. PubMed ID: 18581711
[TBL] [Abstract][Full Text] [Related]
17. Low levels of low-density lipoprotein cholesterol and blood pressure and progression of coronary atherosclerosis.
Chhatriwalla AK; Nicholls SJ; Wang TH; Wolski K; Sipahi I; Crowe T; Schoenhagen P; Kapadia S; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2009 Mar; 53(13):1110-5. PubMed ID: 19324254
[TBL] [Abstract][Full Text] [Related]
18. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
[TBL] [Abstract][Full Text] [Related]
19. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
Superko HR; Garrett BC; King SB; Momary KM; Chronos NA; Wood PD
Am J Cardiol; 2009 Feb; 103(3):387-92. PubMed ID: 19166694
[TBL] [Abstract][Full Text] [Related]
20. The risk of coronary heart disease in men with androgenetic alopecia.
Sasmaz S; Senol M; Ozcan A; Dogan G; Tuncer C; Akyol O; Sener S
J Eur Acad Dermatol Venereol; 1999 Mar; 12(2):123-5. PubMed ID: 10343940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]